tiprankstipranks
Advertisement
Advertisement

DSGN Stock Latest News

Design Therapeutics management to meet with Oppenheimer
The FlyDesign Therapeutics management to meet with Oppenheimer
11d ago
DSGN
Design Therapeutics Appoints David Shapiro to Board
PremiumCompany Announcements
Design Therapeutics Appoints David Shapiro to Board
12d ago
8K
DSGN
Design Therapeutics initiated with a Buy at Jefferies
PremiumThe Fly
Design Therapeutics initiated with a Buy at Jefferies
29d ago
DSGN
Design Therapeutics price target raised to $14 from $13 at RBC Capital
PremiumThe Fly
Design Therapeutics price target raised to $14 from $13 at RBC Capital
1M ago
DSGN
Design Therapeutics reports Q4 EPS (27c), consensus (35c)
PremiumThe Fly
Design Therapeutics reports Q4 EPS (27c), consensus (35c)
1M ago
DSGN
Controversial Prasad leaving FDA, NYT reports
PremiumThe FlyControversial Prasad leaving FDA, NYT reports
1M ago
AZN
BMY
Design Therapeutics announces governance-driven board resignation
Premium
Company Announcements
Design Therapeutics announces governance-driven board resignation
2M ago
8K
DSGN
Design Therapeutics initiated with an Outperform at Oppenheimer
Premium
The Fly
Design Therapeutics initiated with an Outperform at Oppenheimer
3M ago
DSGN
Craig-Hallum bullish on Design Therapeutics, initiates with a Buy
PremiumThe Fly
Craig-Hallum bullish on Design Therapeutics, initiates with a Buy
4M ago
DSGN
Design Therapeutics initiated with a Buy at Craig-Hallum
PremiumThe Fly
Design Therapeutics initiated with a Buy at Craig-Hallum
4M ago
DSGN
Design Therapeutics upgraded to Outperform from Market Perform at Leerink
PremiumThe Fly
Design Therapeutics upgraded to Outperform from Market Perform at Leerink
4M ago
DSGN
Design Therapeutics upgraded to Outperform from Market Perform at Leerink
PremiumThe Fly
Design Therapeutics upgraded to Outperform from Market Perform at Leerink
4M ago
DSGN
RBC upgrades Design Therapeutics to Outperform into ‘more eventful’ 2026
PremiumThe FlyRBC upgrades Design Therapeutics to Outperform into ‘more eventful’ 2026
5M ago
DSGN
Design Therapeutics upgraded to Outperform from Sector Perform at RBC Capital
Premium
The Fly
Design Therapeutics upgraded to Outperform from Sector Perform at RBC Capital
5M ago
DSGN
Design Therapeutics Reports Q3 2025 Financial Results
Premium
Company Announcements
Design Therapeutics Reports Q3 2025 Financial Results
5M ago
DSGN
Design Therapeutics reports Q3 EPS (30c), consensus (34c)
PremiumThe Fly
Design Therapeutics reports Q3 EPS (30c), consensus (34c)
5M ago
DSGN
Design Therapeutics Advances DT-168 Study for Fuchs Dystrophy
PremiumCompany Announcements
Design Therapeutics Advances DT-168 Study for Fuchs Dystrophy
6M ago
DSGN
Design Therapeutics Advances DT-216P2 Study for Friedreich’s Ataxia
PremiumCompany Announcements
Design Therapeutics Advances DT-216P2 Study for Friedreich’s Ataxia
6M ago
DSGN
Design Therapeutics Advances with New Study on DT-216P2 for Friedreich Ataxia
PremiumCompany Announcements
Design Therapeutics Advances with New Study on DT-216P2 for Friedreich Ataxia
6M ago
DSGN
Citizens JMP healthcare analysts hold an analyst/industry conference call
PremiumThe FlyCitizens JMP healthcare analysts hold an analyst/industry conference call
6M ago
BIIB
DSGN
Design Therapeutics Appoints Justin Gover as Director
Premium
Company Announcements
Design Therapeutics Appoints Justin Gover as Director
7M ago
8K
DSGN
Cohen’s Point72 reports 5.2% passive stake in Design Therapeutics
Premium
The Fly
Cohen’s Point72 reports 5.2% passive stake in Design Therapeutics
8M ago
DSGN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >